140 likes | 258 Views
Baseline Predictors for One Year Visual Outcomes with Ranibizumab or Bevacizumab for Neovascular Age-related Macular Degeneration. Ying G-S, Maguire MG , Jaffe GJ, Grunwald JE, Toth C, Daniel E, Klein M, Pieramici D, Wells J, Martin DF for the CATT Research Group
E N D